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Background: Kidney stones in patients with autosomal dominant polycystic kidney disease are common, regarded
as the consequence of the combination of anatomic abnormality and metabolic risk factors. However, complete
staghorn calculus is rare in polycystic kidney disease and predicts a gloomy prognosis of kidney. For general
population, recent data showed metabolic factors were the dominant causes for staghorn calculus, but for
polycystic kidney disease patients, the cause for staghorn calculus remained elusive.
Case presentation: We report a case of complete staghorm calculus in a polycystic kidney disease patient induced
by repeatedly urinary tract infections. This 37-year-old autosomal dominant polycystic kidney disease female with
positive family history was admitted in this hospital for repeatedly upper urinary tract infection for 3 years. CT scan
revealed the existence of a complete staghorn calculus in her right kidney, while there was no kidney stone 3 years
before, and the urinary stone component analysis showed the composition of calculus was magnesium ammonium
phosphate.
Conclusion: UTI is an important complication for polycystic kidney disease and will facilitate the formation of
staghorn calculi. As staghorn calculi are associated with kidney fibrosis and high long-term renal deterioration rate,
prompt control of urinary tract infection in polycystic kidney disease patient will be beneficial in preventing
staghorn calculus formation.
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The incidence of kidney stone in patients with autosomal
dominant polycystic kidney disease (ADPKD) is approxi-
mately 5 to 10 folds of that in the general population
[1-3]. The high incidence of nephrolithiasis is thought to
be the consequence of the combination of anatomic ab-
normality and metabolic risk factors in ADPKD patients
[4]. However, complete staghorn calculus in ADPKD is
rare and the causes of staghorn calculus in ADPKD re-
mains elusive. As existence of staghorn calculus predicts
poor prognosis of kidneys [5,6], the causes for staghorn
calculus in ADPKD are of interests of nephrologists.
Here we report a case of complete staghorm calculus in
an ADPKD patient induced by repeatedly upper urinary
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A 37-year-old ADPKD female patient with positive family
history was admitted in this hospital for repeatedly urinary
tract infection for 3 years. Three years ago, the patient was
admitted in community hospital for urinary tract irritation
with right flank pain and fever for 2 days, and right upper
urinary tract infection was considered. After admission,
bilateral enlarged kidneys full of fluid-filled cysts were
detected by type-B ultrasound examination, and there
were no calculus or crystals in the kidneys detected at
that time. ADPKD was diagnosed considering her family
history. Since then, she suffered from urinary tract infec-
tion every 3–4 months, and urine cultures were negative.
Symptoms usually were relieved within a week with antibi-
otics therapy, but the infections relapsed easily.
One week before admission, this patient’s urinary irrita-
tion relapsed with high fever. As oral antibiotics were not
responsive, she was admitted in this hospital for further
treatment. On admission, her temperature was 39.0°C,
blood pressure 110/82 mmHg. Physical examinationd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tenderness existed in right flank area. Full blood cell count
showed white blood cell count 11.1 × 109/l, hemoglobin
12.3 g/dl and platelets 157 × 109/l. A serum biochemical
profile showed her renal function was normal with
serum creatinine 0.74 mg/dl. Liver function and electro-
lytes were unremarkable. Urinalysis revealed +3 leuko-
cytes, +2 blood, and +1 albumin. Chest radiology and
electrocardiography were reported to be normal. Ab-
dominal CT scan showed enlarged cystic kidneys and a
complete staghorn calculus in the right kidney with no
obvious signs of urinary tract obstruction (Figure 1).
Wide spectrum antibiotics was administered intraven-
ously and the symptoms relieved in 3 days.
Percutaneous nephrolithotomy (PNL) was suggested,
but the patient refused surgery as she felt well after the
symptom relieved and worried about the surgical risks.
To reduce the urinary tract infection and calculus forma-
tion, big volume of water intake was suggested to keep
urinary output more than 2 L a day.
One month after discharge, the patient reported a
“tiny stone” passed with urine, and the urinary stoneFigure 1 CT images of a complete staghorn calculus in the
right kidney in an ADPKD female. Above the staghorn calculus
and polycystic kidney in the coronal plane; Below the three-
dimension reconstructed CT image of calculus and kidney.component analysis showed the composition of calculus
was magnesium ammonium phosphate. Considering the
calculus component and the rapid formation of the
staghorn calculus accompanied by the repeated upper
urinary tract infections, the main cause of the staghorn
calculus was determined as the repeated upper urinary
tract infection in ADPKD.
Conclusions
The incidence of kidney calculus in ADPKD patients
ranges from 8% to 36% [1-3], much higher than in gen-
eral population, while ADPKD with staghorn calculus is
rare. In our center data, there is only one case with
complete staghorn kidney calculus among 412 regularly
followed ADPKD patients (221 male and 191 female) in
the past twelve years.
Calcium oxalate and/or uric acid are the most compo-
nents of kidney stone in ADPKD, although the percent-
age of metabolic disturbances was not higher in ADPKD
patients with kidney calculus than without [2]. Patients
with a larger kidney volume predominant cyst size are at
a higher risk of stone formation [2,4]. Numerous
expanding kidney cysts distort the intrarenal calyceal
system, which leads to urinary stasis and delayed wash-
out of urinary crystals. Hypocitruria, aciduria and low
urinary magnesium are common metabolic defects in
ADPKD, and these factors facillate the formation and
aggregation urinary crystal.
There are no generally accepted causes for the forma-
tion of staghorn calculi in ADPKD. In general popula-
tion, staghorn calculi were traditionally believed to be
synonymous with infection stone, and secondary to of
UTI [7]. However, recent data challenged this traditional
opinion. In a retrospective analysis with 52 kidneys with
complete staghorn calculi, 56% of the kidney stones were
metabolic and 44% were infection stones [8]. The rising
percentage of metabolic stones were also observed in
other urinary stone cases [9,10].
In this case of ADPKD patient, the medical history
and kidney stone component analysis supported that this
case was a typical UTI induced complete staghorn calcu-
lus. This case showed in ADPKD patients, UTI was an
important cause of staghorn calculus. As UTI is very
common in ADPKD with 30%-50% patients experiencing
an episode in their lifetime [11,12], and staghorn calculi
was associated with kidney fibrosis [5] and high long
term renal deterioration rate [6], prompt control of UTI
in ADPKD patient will be beneficial in preventing stag-
horn calculus formation.
For the treatment of staghorn calculi, PNL was recom-
mended as the first therapy for most patients by AUA
guideline in 2005 [7], while shock wave lithotripsy (SWL)
monotherapy and open surgery are only indicated on few
conditions [13]. In ADPKD patients, the principles of
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with normal kidneys, however PNL can be challenging
because of the distortion of kidney anatomy by cysts com-
pression and the cysts can come in the way of puncture
and need to be aspirated before procedure [1,14-16]. As
reports on surgical treatment for nephrolithisasis in
ADPKD patients are limited, it is reasonable to choose
suitable therapeutic modality based on experience and
expertise of each center. After removal of kidney stones,
risk factors evaluation and control should always be con-
sidered to reduce the frequency of recurrent stone disease
in such patients.
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